China Pharma
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $948 | $983 | $1,225 | $756 |
Gross Profit | 83 | -539 | 150 | -59 |
EBITDA | -329 | -136 | -271 | |
EBIT | -1,431 | -1,117 | -627 | |
Net Income | -1,458 | -1,143 | -1,222 | -651 |
Net Change In Cash | 948 | 983 | 1,225 | 756 |
Free Cash Flow | -32 | -55 | 146 | -277 |
Cash | 304 | 168 | 345 | 267 |
Basic Shares | 4,291 | 4,291 | 15,522 | 3,874 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $4,144 | $4,528 | $7,011 | $8,104 |
Gross Profit | -131 | -1,985 | -281 | -493 |
EBITDA | -1,506 | -1,964 | 8 | -837 |
EBIT | -3,085 | -4,582 | -2,745 | -3,538 |
Net Income | -3,187 | -4,736 | -3,078 | -3,972 |
Net Change In Cash | 4,144 | 4,528 | 7,011 | 8,104 |
Free Cash Flow | 11 | -758 | -711 | -811 |
Cash | 345 | 626 | 1,423 | 2,029 |
Basic Shares | 4,291 | 17,463 | 10,599 | 5,256 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.04 |
2025-09-30 | -$0.17 |
2025-06-30 | -$0.16 |
2025-03-31 | -$0.24 |